Preventing Medicare Telefraud Act

Bill 119 hr 1785, also known as the "Medicare DMEPOS Competitive Bidding Improvement Act of 2021," aims to make changes to the Medicare program in order to improve the provision of high-cost durable medical equipment (DME) and laboratory testing.

The bill proposes amendments to Title XVIII of the Social Security Act, which governs the Medicare program. Specifically, it establishes new requirements for the provision of certain high-cost DME and laboratory testing services.

One key provision of the bill is the implementation of a competitive bidding process for DMEPOS (Durable Medical Equipment, Prosthetics, Orthotics, and Supplies) suppliers. This process aims to ensure that Medicare beneficiaries have access to high-quality DME at competitive prices. Additionally, the bill includes provisions to improve the oversight and quality standards for laboratory testing services covered by Medicare. This is intended to ensure that beneficiaries receive accurate and reliable test results. Overall, the goal of Bill 119 hr 1785 is to enhance the efficiency and effectiveness of the Medicare program in providing high-cost DME and laboratory testing services to beneficiaries.